Consumption and market share of cholesterol-lowering drugs in high-risk patients before and after the release of the 2013 ACC/AHA cholesterol guidelines: a retrospective observational study.

ABSTRACT:

Objective

We examined the use of cholesterol-lowering drugs in Taiwan in high-risk patients before and after the release of the 2013 American College of Cardiology and the American Heart Association (ACC/AHA) cholesterol guidelines.

Design

Retrospective observational study.

Setting

Kaohsiung Chang Gung Memorial Hospital database, Kaohsiung City, Taiwan.

Participants

Outpatients aged ≥20 years with atherosclerosis cardiovascular disease, familial hypercholesterolaemia and diabetes.

Primary and secondary outcome measures

Data on brand and generic names, use and dosage of cholesterol-lowering drugs in 2012 and 2015 were compiled and the total amount used was calculated. Differences in usage and market share were compared. Usage rates of single and fixed-dos

SUBMITTER: Kuo TT 

PROVIDER: S-EPMC7682459 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature